Archive:Venalex: Difference between revisions
m →Therapeutic indications: Added links |
m Disambiguating links to Venous insufficiency (link changed to Chronic venous insufficiency) using DisamAssist. |
||
| Line 7: | Line 7: | ||
== Therapeutic indications== | == Therapeutic indications== | ||
Symptomatic treatment of chronic functional or structural [[venous insufficiency]] of the lower limbs. [[Lymphedema]]. Symptomatic treatment of hemorrhoids. Ailments caused by pressure ulcers. No results of clinical trials have been published. Venalax is not approved by the FDA | Symptomatic treatment of chronic functional or structural [[Chronic venous insufficiency|venous insufficiency]] of the lower limbs. [[Lymphedema]]. Symptomatic treatment of hemorrhoids. Ailments caused by pressure ulcers. No results of clinical trials have been published. Venalax is not approved by the FDA | ||
== Dosage == | == Dosage == | ||
Revision as of 09:20, 28 June 2023
Template:Multiple issues Venalex is a micronized purified flavonoid fraction containing 90% diosmin and 10% hesperidin.
Therapeutic indications
Symptomatic treatment of chronic functional or structural venous insufficiency of the lower limbs. Lymphedema. Symptomatic treatment of hemorrhoids. Ailments caused by pressure ulcers. No results of clinical trials have been published. Venalax is not approved by the FDA
Dosage
2 capsules per day. Do not exceed the recommended daily dose. Nutritional supplement cannot substitute for a healthy, balanced diet.
Additional information
Venalex is usually very well tolerated by the body and very rare side effects associated with its use.